Insider Transactions in Q1 2022 at Theseus Pharmaceuticals, Inc. (THRX)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 21
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
111,896
+0.67%
|
$1,007,064
$9.97 P/Share
|
Jan 21
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
111,896
+0.67%
|
$1,007,064
$9.97 P/Share
|
Jan 20
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
35,000
+0.21%
|
$315,000
$9.95 P/Share
|
Jan 20
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
35,000
+0.21%
|
$315,000
$9.95 P/Share
|
Jan 19
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
11,521
+0.07%
|
$103,689
$9.97 P/Share
|
Jan 19
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
11,521
+0.07%
|
$103,689
$9.97 P/Share
|
Jan 13
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
17,320
+0.11%
|
$155,880
$9.43 P/Share
|
Jan 13
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
17,320
+0.11%
|
$155,880
$9.43 P/Share
|
Jan 12
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
18,897
+0.12%
|
$188,970
$10.06 P/Share
|
Jan 12
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
18,897
+0.12%
|
$188,970
$10.06 P/Share
|
Jan 11
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
8,500
+0.03%
|
$85,000
$10.24 P/Share
|
Jan 11
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
8,500
+0.03%
|
$85,000
$10.24 P/Share
|